Friday, April 3

Element One Announces Closing of $1.3 Million Financing Led by Centurion One Capital


Vancouver, British Columbia–(Newsfile Corp. – April 2, 2026) – Element One Hydrogen & Critical Minerals Corp. (CSE: EONE) (“Element One” or the “Company“)  is pleased to announce that it has closed its brokered private placement of 6,233,334 units (the “LIFE Units“) of the Company at the price of $0.15 per LIFE Unit for gross proceeds of approximately $935,000.10 (the “LIFE Offering“), which were previously announced on February 9, 2026 and March 27, 2026.

Concurrent with the LIFE Offering, the Company also closed the first tranche of a brokered private placement of 2,416,667 units (the “Concurrent Units” and together with the LIFE Units, the “Units“) of the Company at a price of $0.15 per Concurrent Unit for gross proceeds of approximately $362,500.05 (the “Concurrent Offering” and together with the LIFE Offering, the “Offerings“). Each Concurrent Unit consists of one common share in the capital of the Company (a “Common Share“) and one Common Share purchase warrant (a “Warrant“). Each Warrant will entitle the holder thereof to purchase one Warrant Share at the exercise price of $0.20 per Warrant Share for a period of 36 months from the closing date of the Concurrent Offering.

Centurion One Capital Corp. (the “Lead Agent“) acted as lead agent and sole bookrunner in connection with the Offerings.

Each LIFE Unit consists of one Common Share and one-half of a Warrant. Each whole Warrant will entitle the holder thereof to purchase one Common Share of the Company (a “Warrant Share“) at the exercise price of $0.20 per Warrant Share for a period of 36 months from the date that is 61 days following the closing date of the LIFE Offering.

In connection with the Offerings, the Company paid the Lead Agent an aggregate cash commission of $103,800.01 and issued an aggregate of 692,000 broker warrants (the “Broker Warrants“). Each Broker Warrant entitles the holder to acquire one Concurrent Unit at a price of $0.15 for a period of three (3) years from the date of issuance. Upon closing of the Offerings, the Company also paid the Lead Agent a corporate finance fee consisting of 416,666 LIFE Units and 448,334 Concurrent Units.

The Company completed the LIFE Offering pursuant to the listed issuer financing exemption under Section 5A.2 of National Instrument 45-106 – Prospectus Exemptions, as amended and supplemented by Coordinated Blanket Order 45-935 (Exemptions from Certain Conditions of the Listed Issuer Financing Exemption) in British Columbia, Alberta and Ontario (the “LIFE Exemption“). The securities issued under the LIFE Exemption are not subject to a statutory hold period pursuant to applicable Canadian securities laws. The Company completed the Concurrent Offering pursuant to the “accredited investor”, the “minimum amount investment” and other available prospectus exemptions under National Instrument 45-106 and other applicable securities regulations. All securities acquired pursuant to the Concurrent Offering are subject to a hold period of four (4) months and one (1) day pursuant to applicable Canadian securities laws.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *